Sunday, October 22, 2017

Treating Acute Pancreatitis with Insulin Offers New Hope

Acute pancreatitis involves the pancreas digesting itself, resulting in severe abdominal pain, vomiting and systemic inflammation. About 80,000 cases occur in the United States each...

Dietary Fructose Causes Liver Damage in Animal Model

The role of dietary fructose in the development of obesity and fatty liver diseases remains controversial, with previous studies indicating that the problems resulted...

Reversing Insulin Resistance to Reduce Type 2 Diabetes

While Regaining Control of Metabolism to Curb Carbohydrate Cravings, Control Weight A recent article in the New York Times reveals that 800,000 New Yorkers – more than...

Fatty Liver And NASH: The Silent Epidemic

With all the attention focused on the twin epidemics of obesity and Type 2 diabetes, few people are aware of another closely related condition that is rapidly becoming another major epidemic. According to the American Liver Association, fatty liver disease – marked by the abnormal accumulation of fat in the liver – currently affects as many as one in five Americans.